Last reviewed · How we verify

NCT05283668

Effect of Injectable Platelet Rich Fibrin on Healing and Patient Satisfaction Following Laser Gingival Depigmentation

Completed Phase 4 Last updated 17 March 2022
What this trial tests

Phase 4 trial testing i-PRF in Gingival Pigmentation in 8 participants. Completed in 30 January 2022.

Timeline
20 February 2020
Primary endpoint
20 January 2022
30 January 2022

Quick facts

Lead sponsorAin Shams University
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment8
Start date20 February 2020
Primary completion20 January 2022
Estimated completion30 January 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 16 to 45, any sex, with Gingival Pigmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objectives of the present study are to: 1. Evaluate the effect of I-PRF injection following laser gingival depigmentation technique on the healing period as a primary objective. 2. Assess patient satisfaction following the procedure in terms of pain and esthetic outcome as a secondary objective.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Injectable platelet rich fibrin effect on laser depigmented gingiva: a clinical randomized controlled split mouth trial with histological assessment.
    Ibrahim SSA, Mandil IA, Ezzatt OM. · · 2024 · cited 4× · PMID 38536994 · DOI 10.1590/1678-7757-2022-0307

Verify or expand the search:

Other trials of i-PRF

Trials testing the same drug.

Other recruiting trials for Gingival Pigmentation

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05283668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing